Merck Seeks Emergency Use Authorization for Antiviral COVID-19 Treatment Molnupiravir

Merck and Ridgeback Biotherapeutics said Monday that it is seeking emergency use authorization for its antiviral treatment, molnupiravir.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting